CIK: 1280564 - Address: C/o Bellerophon Therapeutics, Inc., 53 Frontage Road, Suite 301, Hampton, NJ 08827
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret21618-0-12-42-37-14
P%wins83673317171739
S%ret111012-4-13-37-10
S%wins1000010010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/22/15 07:32
5/20/15
BLPHBellerophon Therapeutics, Inc.HealthDrugPharmaceutical PreparationsMeglasson MartinNJOChief ScP68.4001419D-4-9-341003-16-39-68-86
2/23/15 21:39
2/19/15
BLPHBellerophon Therapeutics, Inc.HealthDrugPharmaceutical PreparationsMeglasson MartinNJOChief ScP14412.0031218818D2-2256-6-44-78
5/11/10 14:14
5/11/10
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscP101.63067102D-51-46-136-4-7-12-100-2-6-3110
5/9/08 13:53
5/9/08
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscP103.3603937D-61-51-37-21-13-17-18-904-7-12-57-10
8/30/07 19:04
8/30/07
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscP126.19121714D3-15-29-8-1100-70-1-15-28-47-47
12/19/06 18:51
12/15/06
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscM.d397.25151D-812270231012-4-13-37
12/19/06 18:51
12/15/06
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscS.d-6011.231-5-911D-812270231012-4-13-37
11/12/04 17:11
11/11/04
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMeglasson MartinCAOV-P,DiscP48.8221New1D29-29-484-1234-68193619-34-10

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact